Anticoagulants Market by Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), by Route of Administration (Injectable Anticoagulant and Oral Anticoagulant), and by Application (Stroke, Atrial Fibrillation, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

  • TBI357276
  • July 24, 2020
  • Global
  • 132 pages
  • SAC Insights


The report covers a forecast and an analysis of the anticoagulants market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the anticoagulants market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the anticoagulants market on a global and regional level. In order to give the users of this report a comprehensive view of the anticoagulants market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis to give a broader overview of the key players in the anticoagulants market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the anticoagulants market on a global and regional basis. The study provides a decisive view of the anticoagulants market based on drug class, route of administration, application, and region. By drug class, the anticoagulants market is segmented into NOACs, heparin and LMWH, vitamin K antagonist, and others. The NOACs is sub-segmented into bevyxxa, eliquis, lixiana and savaysa, pradaxa, and xarelto. The route of administration segment is divided into injectable anticoagulant and oral anticoagulant. The application segment is segmented into stroke, atrial fibrillation, pulmonary embolism (PE), deep vein thrombosis (DVT), and others. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further fragmented into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. Some players of the global anticoagulants market are Bayer AG, Aspen Holdings, Boehringer Ingelheim GmbH, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, and Portola Pharmaceuticals, Inc., among others. This report segments the global anticoagulants market as follows: Global Anticoagulants Market: By Drug Class NOACs Bevyxxa Eliquis Lixiana and Savaysa Pradaxa Xarelto Heparin and LMWH Vitamin K Antagonist Others Global Anticoagulants Market: By Route of Administration Injectable Anticoagulant Oral Anticoagulant Global Anticoagulants Market: By Application Stroke Atrial Fibrillation Pulmonary Embolism (PE) Deep vein thrombosis (DVT) Others Global Anticoagulants Market: By Region North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

Table of Contents
                         Request Table Of Content
                         Click To Request Sample

	Chapter 1. Introduction
		1.1. Report description and scope
		1.2. Research scope
		1.3. Research methodology
			1.3.1. Market research process
			1.3.2. Market research methodology
	Chapter 2. Executive Summary
		2.1. Global Anticoagulants market, 2016-2025 (USD Billion)
		2.2. Global Anticoagulants market: Snapshot
	Chapter 3. Anticoagul
| 

Request a sample

Fill below form to request a sample


Please fill this form to enquire before buying


You can request for discount regarding the report by using below form